Bristol-Myers Squibb Company (BMY) Reports Fourth Quarter And Full Year 2013 Financial Results
1/24/2014 6:55:16 AM
Bristol-Myers Squibb Company (NYSE:BMY) today reported results for the fourth quarter and full year of 2013. The fourth quarter was highlighted by the company’s announcement to sell its diabetes business as part of the continued evolution of its successful BioPharma strategy to a specialty care model. The company achieved important regulatory milestones in the quarter for Eliquis in the U.S., daclatasvir/asunaprevir in Japan, daclatasvir in Europe and Farxiga in the U.S. In addition, the company provided financial guidance for 2014.
Help employers find you! Check out all the jobs and post your resume.
comments powered by